EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeit

The Burden of Chronic Rhinosinusitis Without Nasal Polyps: A Systematic Review of Epidemiological, Clinical, Humanistic, and Economic Evidence

Anju T Peters, Catherine Rolland, Louis Lavoie, Selwyn Fung, Daniel Basoff, Abhishek Chitnis

Advances in Therapy · 2026-07 · 43 (7) · 2871-2896

DOI: 10.1007/s12325-026-03575-7 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Advances in Therapy, online erschienen am 30.04.2026. Verfasst von Anju T Peters und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Hauptthemen laut MEDLINE: Rhinosinusitis, Cost of Illness, Sinusitis, Rhinitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Insmed.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic rhinosinusitis (CRS) is a heterogeneous and often debilitating disease characterized by persistent sinonasal symptoms and inflammation and is phenotypically classified as CRS with nasal polyps (CRSwNP) or without nasal polyps (CRSsNP). Although CRSsNP is the more prevalent phenotype (approximately 80%), it remains disproportionately understudied, leading to critical gaps in understanding and management. This systematic literature review synthesized current global evidence on the epidemiological, clinical, humanistic, and economic burden of CRSsNP, highlighting areas of unmet need and raising awareness of the impact of this disease. PRISMA-compliant searches were conducted for CRSsNP records published 2004-2024 (epidemiological studies 2014-2024) across six electronic databases. Targeted hand searches were performed for abstracts (2022-2024), health technology assessments, guidelines, and clinical trial registries. Of 2215 records identified, 157 met inclusion criteria. CRSsNP prevalence was 4.3-10.4% in the USA, South Korea, and Spain. Patients experienced a range of symptoms including nasal/sinus (obstruction, discharge, crusting), pain, sensory (anosmia, cacosmia), respiratory (cough, asthma), oral (dry throat, halitosis), and sleep impairment. There was considerable variability in the availability and use of tools to assess severity; this impeded cross-study comparisons, consistent disease staging, and treatment escalation criteria. Associated comorbidities included asthma, chronic obstructive pulmonary disease, gastroesophageal reflux disease, and primary antibody deficiencies. Humanistic burden was assessed using a variety of outcome measures and was higher for patients with CRSsNP than for controls. Limited data were available on economic burden. Currently available therapies were associated with high rates of treatment failure, inadequately controlled symptoms, and the need for multiple lines of therapy. CRSsNP is associated with considerable burden across clinical, humanistic, and economic domains, exacerbated by diagnostic variability, treatment limitations, and a lack of standardized research methodologies. This highlights the need for coordinated efforts among stakeholders to better address this chronic condition and support future improvements in patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhinosinusitisCost of IllnessSinusitisRhinitisHumansChronic DiseaseNasal PolypsPrevalenceSymptom BurdenQuality of Life

Stichwörter der Autor:innen

Chronic rhinosinusitis without nasal polypsClinical burdenEconomic burdenHealth-related quality of lifeHumanistic burdenSystematic literature review

Autor:innen und Institutionen

  • Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Health Economic and Market Access, Modelling and Communications, PPD Evidera, London, UK.
  • Health Economic and Market Access, Modelling and Communications, PPD Evidera, Montreal, Canada.
  • Health Economics and Outcomes Research, Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA.
  • Health Economics and Outcomes Research, Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA. abhishek.chitnis@insmed.com.

Förderung

  • Insmed

Zitieren

APA

Peters, A. T., Rolland, C., Lavoie, L., Fung, S., Basoff, D., & Chitnis, A. (2026). The Burden of Chronic Rhinosinusitis Without Nasal Polyps: A Systematic Review of Epidemiological, Clinical, Humanistic, and Economic Evidence. Advances in Therapy, 43(7), 2871-2896. https://doi.org/10.1007/s12325-026-03575-7

Vancouver

Peters AT, Rolland C, Lavoie L, Fung S, Basoff D, Chitnis A. The Burden of Chronic Rhinosinusitis Without Nasal Polyps: A Systematic Review of Epidemiological, Clinical, Humanistic, and Economic Evidence. Advances in Therapy. 2026;43(7):2871-2896. doi:10.1007/s12325-026-03575-7

BibTeX
@article{Peters2026,
  author = {Peters, Anju T and Rolland, Catherine and Lavoie, Louis and Fung, Selwyn and Basoff, Daniel and Chitnis, Abhishek},
  title = {The Burden of Chronic Rhinosinusitis Without Nasal Polyps: A Systematic Review of Epidemiological, Clinical, Humanistic, and Economic Evidence},
  journal = {Advances in Therapy},
  year = {2026},
  volume = {43},
  number = {7},
  pages = {2871--2896},
  doi = {10.1007/s12325-026-03575-7}
}
Kostenlos starten →